Agreement between different recall periods in drug utilization studies
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista brasileira de epidemiologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2017000200324 |
Resumo: | ABSTRACT: Objective: To assess the agreement between three recall periods for self-reported drug use using a 24-hour recall period as reference. Methods: Participants were allocated into three groups with different recall periods of 7, 14 and 30 days and were interviewed at two different times. A 24-hour recall questionnaire was answered during the first interview, and a questionnaire on drug use over the different recall periods tested was answered during the second interview. The agreement between the questionnaires was evaluated using percent agreement and kappa. Results: For continuous drugs, percent agreement varied between 92 and 99% and kappa varied between 0.71 and 0.97 for three periods tested. For drugs of occasional use, percent agreement varied between 63 and 81% and kappa varied between 0.27 and 0.52. The prevalence of drugs, particularly those of occasional use, increases with time. Conclusions: The high level of agreement between the three recall periods suggests that all of them are valid for the investigation of drugs of continuous use. |
id |
ABRASCO-1_3564965850e82ffdeb3cd987010c889c |
---|---|
oai_identifier_str |
oai:scielo:S1415-790X2017000200324 |
network_acronym_str |
ABRASCO-1 |
network_name_str |
Revista brasileira de epidemiologia (Online) |
repository_id_str |
|
spelling |
Agreement between different recall periods in drug utilization studiesDrug utilizationQuestionnairesSelf reportMental recallValidation studiesPharmacoepidemiologyABSTRACT: Objective: To assess the agreement between three recall periods for self-reported drug use using a 24-hour recall period as reference. Methods: Participants were allocated into three groups with different recall periods of 7, 14 and 30 days and were interviewed at two different times. A 24-hour recall questionnaire was answered during the first interview, and a questionnaire on drug use over the different recall periods tested was answered during the second interview. The agreement between the questionnaires was evaluated using percent agreement and kappa. Results: For continuous drugs, percent agreement varied between 92 and 99% and kappa varied between 0.71 and 0.97 for three periods tested. For drugs of occasional use, percent agreement varied between 63 and 81% and kappa varied between 0.27 and 0.52. The prevalence of drugs, particularly those of occasional use, increases with time. Conclusions: The high level of agreement between the three recall periods suggests that all of them are valid for the investigation of drugs of continuous use.Associação Brasileira de Saúde Coletiva2017-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2017000200324Revista Brasileira de Epidemiologia v.20 n.2 2017reponame:Revista brasileira de epidemiologia (Online)instname:Associação Brasileira de Saúde Coletiva (ABRASCO)instacron:ABRASCO10.1590/1980-5497201700020012info:eu-repo/semantics/openAccessMoraes,Cassia GarciaMengue,Sotero SerratePizzol,Tatiane da Silva Daleng2017-08-17T00:00:00Zoai:scielo:S1415-790X2017000200324Revistahttp://www.scielo.br/rbepidhttps://old.scielo.br/oai/scielo-oai.php||revbrepi@usp.br1980-54971415-790Xopendoar:2017-08-17T00:00Revista brasileira de epidemiologia (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)false |
dc.title.none.fl_str_mv |
Agreement between different recall periods in drug utilization studies |
title |
Agreement between different recall periods in drug utilization studies |
spellingShingle |
Agreement between different recall periods in drug utilization studies Moraes,Cassia Garcia Drug utilization Questionnaires Self report Mental recall Validation studies Pharmacoepidemiology |
title_short |
Agreement between different recall periods in drug utilization studies |
title_full |
Agreement between different recall periods in drug utilization studies |
title_fullStr |
Agreement between different recall periods in drug utilization studies |
title_full_unstemmed |
Agreement between different recall periods in drug utilization studies |
title_sort |
Agreement between different recall periods in drug utilization studies |
author |
Moraes,Cassia Garcia |
author_facet |
Moraes,Cassia Garcia Mengue,Sotero Serrate Pizzol,Tatiane da Silva Dal |
author_role |
author |
author2 |
Mengue,Sotero Serrate Pizzol,Tatiane da Silva Dal |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Moraes,Cassia Garcia Mengue,Sotero Serrate Pizzol,Tatiane da Silva Dal |
dc.subject.por.fl_str_mv |
Drug utilization Questionnaires Self report Mental recall Validation studies Pharmacoepidemiology |
topic |
Drug utilization Questionnaires Self report Mental recall Validation studies Pharmacoepidemiology |
description |
ABSTRACT: Objective: To assess the agreement between three recall periods for self-reported drug use using a 24-hour recall period as reference. Methods: Participants were allocated into three groups with different recall periods of 7, 14 and 30 days and were interviewed at two different times. A 24-hour recall questionnaire was answered during the first interview, and a questionnaire on drug use over the different recall periods tested was answered during the second interview. The agreement between the questionnaires was evaluated using percent agreement and kappa. Results: For continuous drugs, percent agreement varied between 92 and 99% and kappa varied between 0.71 and 0.97 for three periods tested. For drugs of occasional use, percent agreement varied between 63 and 81% and kappa varied between 0.27 and 0.52. The prevalence of drugs, particularly those of occasional use, increases with time. Conclusions: The high level of agreement between the three recall periods suggests that all of them are valid for the investigation of drugs of continuous use. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2017000200324 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2017000200324 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1980-5497201700020012 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Saúde Coletiva |
publisher.none.fl_str_mv |
Associação Brasileira de Saúde Coletiva |
dc.source.none.fl_str_mv |
Revista Brasileira de Epidemiologia v.20 n.2 2017 reponame:Revista brasileira de epidemiologia (Online) instname:Associação Brasileira de Saúde Coletiva (ABRASCO) instacron:ABRASCO |
instname_str |
Associação Brasileira de Saúde Coletiva (ABRASCO) |
instacron_str |
ABRASCO |
institution |
ABRASCO |
reponame_str |
Revista brasileira de epidemiologia (Online) |
collection |
Revista brasileira de epidemiologia (Online) |
repository.name.fl_str_mv |
Revista brasileira de epidemiologia (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO) |
repository.mail.fl_str_mv |
||revbrepi@usp.br |
_version_ |
1754212954968948736 |